Swift Medical, a digital health technology company serving wound care providers, announces the successful closing of an $US8M round of financing co-led by current investors BDC Capital’s Women in Technology Venture Fund and funds managed by Virgo Investment Group. Swift utilizes artificial intelligence to improve clinical and economic outcomes in chronic and acute wound care, and this financing accelerates its pace of technology enhancements.
“Swift has built a market leading wound care tool that improves outcomes for patients and streamlines the busy workflows for providers. We are delighted to have the support of our existing and new investors. This financing enables us to expand our reach and enhance our technology, further revolutionizing wound care and impacting patient care,” said Brian Litten, CEO of Swift Medical.
Michelle Scarborough, Managing Partner, Thrive Venture Fund and Women in Technology Venture Fund at BDC Capital stated, “We are extremely proud to be part of Swift Medical’s journey and this new funding round demonstrates our continued confidence in their dedication to improving wound care through technology.”
Swift is excited to deliver significant enhancements to its platform in 2024 including enhanced data security, improved interoperability, and enhanced device capabilities. These initiatives aim to elevate the customer experience and drive excellence in healthcare technology.” Swift Medical is transforming the standard of wound care,” said Dwayne Sansone, Managing Director, Virgo. “We are excited to continue of partnership with Swift to drive positive change in the digital wound care space.”
![Image: [image credit]](/wp-content/themes/yootheme/cache/8d/dreamstime_l_142816673-scaled-8df03a7e.jpeg)
